METASTATIC HER2-NEGATIVE BREAST CARCINOMA
Clinical trials for METASTATIC HER2-NEGATIVE BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC HER2-NEGATIVE BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC HER2-NEGATIVE BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Radioactive bullets target bone tumors in breast cancer trial
Disease control OngoingThis study tests a combination of a radioactive drug (radium-223) and chemotherapy (paclitaxel) in 70 people with advanced breast cancer that has spread to the bones. The radioactive drug acts like calcium and collects in bone tumors to kill cancer cells and ease pain. The goal i…
Matched conditions: METASTATIC HER2-NEGATIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 02:20 UTC
-
New drug shows promise for breast cancer brain tumors
Disease control OngoingThis study tests a drug called sacituzumab govitecan in 44 people with HER2-negative breast cancer that has spread to the brain. The drug works like a smart bomb, attaching to cancer cells and delivering chemotherapy directly to them. The goal is to see if it can shrink brain tum…
Matched conditions: METASTATIC HER2-NEGATIVE BREAST CARCINOMA
Phase: PHASE2 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New drug cocktail shows promise for Hard-to-Treat breast cancer
Disease control OngoingThis study tests whether adding a drug called copanlisib to the usual two-drug therapy (fulvestrant and abemaciclib) works better for people with a certain type of advanced breast cancer (hormone receptor-positive, HER2-negative) that has spread. About 24 participants will receiv…
Matched conditions: METASTATIC HER2-NEGATIVE BREAST CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 11, 2026 20:48 UTC